These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 10502122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P.
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [Abstract] [Full Text] [Related]

  • 3. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H.
    Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum β₂-GPI-Lp(a) complexes levels in children with nephrotic syndrome.
    Zhang C, Luo Y, Huang Z, Xia Z, Cai X, Yang Y, Niu D, Wang J.
    Clin Chim Acta; 2012 Oct 09; 413(19-20):1657-60. PubMed ID: 22609258
    [Abstract] [Full Text] [Related]

  • 5. The level of native and oxidized lipoprotein(a) in children with nephrotic syndrome.
    Li HQ, Wu J, Niu DM, Shi YH, Zhang CN, Wang JJ.
    Clin Biochem; 2012 Jan 09; 45(1-2):101-5. PubMed ID: 22122998
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.
    Noto D, Barbagallo CM, Cascio AL, Cefalù AB, Cavera G, Caldarella R, Marino G, Travali S, Cutaia I, Maringhini S, Notarbartolo A, Averna M.
    Kidney Int; 1999 Jun 09; 55(6):2433-9. PubMed ID: 10354292
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lipoprotein(a) in the nephrotic syndrome: molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine.
    Doucet C, Mooser V, Gonbert S, Raymond F, Chapman J, Jacobs C, Thillet J.
    J Am Soc Nephrol; 2000 Mar 09; 11(3):507-513. PubMed ID: 10703674
    [Abstract] [Full Text] [Related]

  • 12. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD, Azrolan N, Thomas L, Roberts KG, Bostom A, Zhao ZH, Friedman EA.
    Am J Kidney Dis; 1995 Jul 09; 26(1):170-7. PubMed ID: 7611249
    [Abstract] [Full Text] [Related]

  • 13. Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.
    Greiber S, Wanner C.
    Miner Electrolyte Metab; 1997 Jul 09; 23(3-6):161-5. PubMed ID: 9387108
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Lipoprotein(a) concentrations and apolipoprotein(a) phenotype frequencies in cord blood of newborn infants and sera of children in Japan].
    Shimura Y, Tanaka T, Ohtani H.
    Rinsho Byori; 1997 Mar 09; 45(3):255-9. PubMed ID: 9086832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.